Discover recent clinical trial failures in depression and explore potential pathways for advancing antidepressant drug ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Artificial intelligence can help. The stories below highlight startup companies that use AI to spot patterns that humans ...

Mounjaro (tirzepatide) is an FDA-approved antidiabetic injection gaining popularity for its effectiveness in weight ...

Despite a crowded GLP-1 drug development field, Structure's oral small molecule approach and strong financial position offer ...

Medication options are available to help manage the cognitive and behavioral symptoms of dementia and Alzheimer's disease.

Eli Lilly and Company (India) has launched 'Mounjaro,' a novel medication for obesity and type 2 diabetes, after receiving ...

Domain Therapeutics SA has nominated PAR2 antagonist DT-9046 as a drug candidate with potential to treat various inflammatory ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

Benadryl is an antihistamine medication that treats mild to severe allergic reactions. It can also help with motion sickness and Parkinson’s disease symptoms. Benadryl can be taken as a sleep aid but ...

Triple negative breast cancer accounts for 15% of cases but causes a disproportionate number of deaths. Learn about symptoms ...